These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2677939)

  • 21. [Clinical phase I trial of a new anti-neoplastic drug--glyciphosphoramide].
    Sun Y
    Zhonghua Zhong Liu Za Zhi; 1984 Jul; 6(4):293-5. PubMed ID: 6525950
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacology and toxicology of chemotherapeutic agents.
    Rodrigues RL
    Emerg Med Clin North Am; 1993 May; 11(2):431-43. PubMed ID: 8491115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase and anthracyclines.
    Ronghe M; Burke GA; Lowis SP; Estlin EJ
    Cancer Treat Rev; 2001 Dec; 27(6):327-37. PubMed ID: 11908926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical evaluation of glyciphosphoramide used alone and in combination with other drugs].
    Wang ZY
    Zhonghua Zhong Liu Za Zhi; 1984 Sep; 6(5):379-81. PubMed ID: 6398774
    [No Abstract]   [Full Text] [Related]  

  • 25. The clinical pharmacology and use of antineoplastic drugs.
    Greco FA; Hande KR
    J Tenn Med Assoc; 1979 Jan; 72(1):23-33. PubMed ID: 423575
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacokinetics and pharmacodynamics of anticancer agents: contributions to the therapy of childhood cancer.
    Petros WP; Evans WE
    Pharmacotherapy; 1990; 10(5):313-25. PubMed ID: 2235668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Action of drugs on microtubules.
    Wilson L
    Life Sci; 1975 Aug; 17(3):303-9. PubMed ID: 1099380
    [No Abstract]   [Full Text] [Related]  

  • 28. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.
    Zamora JM; Pearce HL; Beck WT
    Mol Pharmacol; 1988 Apr; 33(4):454-62. PubMed ID: 3162758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antineoplastic drugs: clinical pharmacology and therapeutic use.
    Bender RA; Zwelling LA; Doroshow JH; Locker GY; Hande KR; Murinson DS; Cohen M; Myers CE; Chabner BA
    Drugs; 1978 Jul; 16(1):46-87. PubMed ID: 78795
    [No Abstract]   [Full Text] [Related]  

  • 30. New vinca alkaloids and related compounds.
    Budman DR
    Semin Oncol; 1992 Dec; 19(6):639-45. PubMed ID: 1462165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between calcium channel blockers and non-cardiovascular drugs: interactions with anticancer drugs.
    Baeyens JM
    Pharmacol Toxicol; 1988 Jul; 63(1):1-7. PubMed ID: 3041398
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics and metabolism of vinca alkaloids.
    Rahmani R; Zhou XJ
    Cancer Surv; 1993; 17():269-81. PubMed ID: 8137344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The oncobiogram-- an indicator of chemotherapy in solid malignant human tumors].
    Schönfelder M
    Zentralbl Chir; 1974 Sep; 99(38):1198-208. PubMed ID: 4454780
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanism of resistance to anthracyclines and vinca alkaloids.
    Danø K; Skovsgaard T; Nissen NI; Friche E; Di Marco A
    Prog Clin Biol Res; 1983; 132C():231-46. PubMed ID: 6579564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of anticancer drugs in children.
    Crom WR; Glynn-Barnhart AM; Rodman JH; Teresi ME; Kavanagh RE; Christensen ML; Relling MV; Evans WE
    Clin Pharmacokinet; 1987 Mar; 12(3):168-213. PubMed ID: 3555940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights into oxazaphosphorine resistance and possible approaches to its circumvention.
    Zhang J; Tian Q; Chan SY; Duan W; Zhou S
    Drug Resist Updat; 2005 Oct; 8(5):271-97. PubMed ID: 16154799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Podophyllotoxin derivatives as an excellent anticancer aspirant for future chemotherapy: A key current imminent needs.
    Zhang X; Rakesh KP; Shantharam CS; Manukumar HM; Asiri AM; Marwani HM; Qin HL
    Bioorg Med Chem; 2018 Jan; 26(2):340-355. PubMed ID: 29269253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies on the mechanism of multidrug resistance].
    Inaba M
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):807-14. PubMed ID: 3471182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New anticancer agents: recent developments in tumor therapy.
    Ali R; Mirza Z; Ashraf GM; Kamal MA; Ansari SA; Damanhouri GA; Abuzenadah AM; Chaudhary AG; Sheikh IA
    Anticancer Res; 2012 Jul; 32(7):2999-3005. PubMed ID: 22753764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticancer chemotherapy.
    Davey P; Tudhope GR
    Br Med J (Clin Res Ed); 1983 Jul; 287(6385):110-3. PubMed ID: 6407699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.